Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may be linked to Peyronie’s disease, but more research is needed.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Photobiomodulation may help with hair growth and wound healing, but research is inconsistent and needs better quality studies.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

UK stem-cell clinics often mislead about treatment safety and effectiveness, needing better regulation.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Using electronic health records can help identify drug side effects but has some limitations.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Most UK survey participants had negative side effects from botulinum toxin injections, with many not fully recovering physically, emotionally, or financially.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

A blood pressure drug, diltiazem, may also help treat influenza.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

A man developed a serious muscle breakdown condition after using a hair loss medication not known to cause this side effect.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The document concludes that terbinafine is effective for treating scalp fungal infections in children and recommends not excluding them from school during treatment, while also highlighting the need for updated treatment guidelines due to changing infection patterns.